2018-01-31 |
38 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,855,246 B2; . (Noreika, Maryellen…2017
25 July 2018
1:17-cv-00799
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2017-06-21 |
4 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,173,707 B2; 8,586,633 B2; 9,066,856…2017
25 July 2018
1:17-cv-00799
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2018-03-05 |
46 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,855,246 B2; . (Noreika, Maryellen…2017
25 July 2018
1:17-cv-00799
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2018-07-24 |
71 |
Stipulation of Dismissal |
Paragraph III Certification with respect to U.S. Patents 8,173,707; 8,586,633;
9,066,856; 9,278,101…submitted a patent amendment to its pending ANDA
207841 in which it revised its Patent and Exclusivity… after the expiration of these
patents, this action and all claims and defenses asserted…2017
25 July 2018
1:17-cv-00799
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2018-07-25 |
72 |
Order |
Paragraph III Certification with respect to U.S. Patents 8,173,707; 8,586,633;
9,066,856; 9,278,101…submitted a patent amendment to its pending ANDA
207841 i.n which it revised its Patent and Exclusivity… after the expiration of these
patents, this action and all claims and defenses asserted…2017
25 July 2018
1:17-cv-00799
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2018-07-26 |
73 |
Order |
Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,713,707 B2; 8,586,633 B2; 9,066,856…2017
25 July 2018
1:17-cv-00799
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |